Alzheimer's Archives -

Alzheimer’s disease could be diagnosed from a single MRI brain scan, according to a new study by Imperial

Single MRI-based brain scan could diagnose Alzheimer’s disease, says study

https://pharmaphorum.com/news/single-mri-based-brain-scan-alzheimers-disease/

R&D/ Views & Analysis/ Views and analysis

Early diagnosis key to future Alzheimer’s treatments

mike.hammerton@pharmaphorum.com Aduhelm, Alzheimer's, Alzheimer's Research UK, Biogen, Lilly, RetiSpec 0 Comment

The approval of Biogen’s Alzheimer’s treatment could herald a new generation of therapies, but before that can happen,

Early diagnosis key to future Alzheimer’s treatments

https://pharmaphorum.com/r-d/early-diagnosis-key-to-future-alzheimers-treatments/

Market Access/ News/ News

Double resignation over Aduhelm approval depletes FDA’s CNS adcomm

Phil Taylor aducanumab, Aduhelm, Alzheimer's, amyloid, Biogen, central nervous system, fda, neurology, regulatory 0 Comment

Two members of an FDA advisory committee have now resigned in protest over Monday’s approval of Biogen’s Alzheimer’s

Double resignation over Aduhelm approval depletes FDA’s CNS adcomm

https://pharmaphorum.com/news/double-resignation-over-aduhelm-approval-depletes-fdas-cns-adcomm/

News/ News/ R&D

Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s ruling

Richard Staines Alzheimer's, Biogen, ophthalmology, X-linked retinitis pigmentosa 0 Comment

Biogen has downbeat news about its gene therapy for the rare inherited eye disease, X-linked retinitis pigmentosa, announcing

Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s ruling

https://pharmaphorum.com/news/biogens-eye-disease-gene-therapy-fails-ahead-of-fda-alzheimers-ruling/

Digital/ R&D/ Video/ Views & Analysis/ Views & Analysis/ Views and analysis

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

Paul Tunnah ALS, Alzheimer's, artificial intelligence, digital health, health innovators, nQ Medical, Parkinson's 0 Comment

In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist

Health Innovators: Teresa Arroyo-Gallego, nQ Medical

https://pharmaphorum.com/video/health-innovators-teresa-arroyo-gallego-nq-medical/

Digital/ Views & Analysis/ Views and analysis

Can your typing patterns reveal if you have Alzheimer’s?

George Underwood Alzheimer's, Alzheimer's disease, dementia, diagnostics, neuroQWERTY, nQ Medical, screening 0 Comment

The neuroQWERTY technology can analyse people’s typing for signs of motor conditions like Parkinson’s disease – and now

Can your typing patterns reveal if you have Alzheimer’s?

https://pharmaphorum.com/views-and-analysis/can-your-typing-patterns-reveal-if-you-have-alzheimers/

Events/ Events/ R&D

2nd Gene Therapy for Neurological Disorders Europe

Ellie Saunders Alzheimer's, CNS, gene therapy, neurological disorders, Parkinson's 0 Comment

Maximising the Opportunity in CNS Gene Therapies

2nd Gene Therapy for Neurological Disorders Europe

https://pharmaphorum.com/events/2nd-gene-therapy-for-neurological-disorders-europe/

News/ News/ R&D

FDA grew too close to Biogen during Alzheimer’s drug development, doctors say

Richard Staines aducanumab, Alzheimer's, Biogen, Eisia, neurology, R&D 0 Comment

The FDA got too close to Biogen during the development of the Alzheimer’s drug aducanumab, according to its

FDA grew too close to Biogen during Alzheimer’s drug development, doctors say

https://pharmaphorum.com/news/fda-grew-too-close-to-biogen-during-alzheimers-drug-development-doctors-say/

News/ News/ R&D

Biogen shares soar as FDA delays decision on aducanumab

Richard Staines aducanumab, Alzheimer's, fda, neurology 0 Comment

The FDA has delayed its decision on aducanumab, the troubled Alzheimer’s drug from Biogen and Eisai by three

Biogen shares soar as FDA delays decision on aducanumab

https://pharmaphorum.com/news/biogen-shares-soar-as-fda-delays-decision-on-aducanumab/

Trending

Alzheimer’s

Login